Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolic acid for injection in acute ischemic stroke
ChiCTR2200055219Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of danshen polyphenolic acid in ischemic stroke, sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Modified Rankin Scale. Started Dec 2021; status: recruiting.
02
Drugs
danshen polyphenolic acid
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2200055219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055219.